Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days